Status:

UNKNOWN

Metformin Therapy in Type 1 Diabetes Mellitus.

Lead Sponsor:

Poznan University of Medical Sciences

Conditions:

Loss of Control of Diabetes

Eligibility:

All Genders

18-60 years

Brief Summary

The use of exogenous insulin and incorrect nutritional habits are conducive to obesity and excess weight. This leads to the development of insulin resistance, even in patients with type 1 diabetes mel...

Eligibility Criteria

Inclusion

  • age \> 18 years \<60 years,
  • duration of diabetes \>3 years,
  • lack of metabolic control- HbA1C\>7,5% (despite participation in 5-day WHO education program)
  • treated with intensive insulin therapy

Exclusion

  • metabolically decompensate diabetes with acetonuria,
  • suspected lack of compliance,
  • lack of glucose and ketones self-monitoring,
  • hypoglycaemic unawareness or recurrent severe hypoglycemia (defined as more than two episodes of hypoglycemia lowered than 60 mg/dl with loss of consciousness, required assistance to treat) in the past 3 months,
  • recurrent diabetic ketoacidosis (more than two episodes in the past year)
  • another serious medical illness,
  • pregnancy or sexually active woman unwilling to take birth control.
  • renal impairment (estimated on the value calculated glomerular filtration rate using the MDRD formula-estimated glomerular filtration rate, eGFR\<45 mL / min
  • liver cell damage Alanine aminotransferase (ALT), Aspartate aminotransferase (AST) greater than twice the upper normal limit),
  • history of drug or alcohol abuse or those who used this drug before
  • changes in the way of antihypertensive and antihyperlipemic treatment.

Key Trial Info

Start Date :

January 1 2009

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

February 1 2014

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT01889706

Start Date

January 1 2009

End Date

February 1 2014

Last Update

June 28 2013

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Internal Medicine and Diabetology, Raszeja Hospital

Poznan, Great Poland, Poland, 60-834